Literature DB >> 31550771

[The significance and latest progress of extrathyroidal extension of thyroid cancer].

L Huang1, C Li1, W Wang1, Y C Cai1, R H Sun1, J Jiang1, Y Q Zhou1, C Y Shui1, W Liu1, X Wang1.   

Abstract

Extrathyroidal extension of thyroid cancer has been an important adverse factor affecting the prognosis of patients. According to the latest NCCN (National Comprehensive Cancer Network) guidelines, extrathyroidal extension is the surgical guide fortotal thyroidectomy in newly diagnosed patients, and its incidence in differentiated thyroid cancer is 5%-34%, belonging to T3-T4 stage.In the eighth edition of thyroid cancer AJCC staging, the T3 stage was first divided into T3a (tumor>4 cm and limited to the thyroid) and T3b (gross extrathyroidal extension invading only strap muscles from a tumor of any size), and the "minimal extrathyroidal extension(tumor invasion intoperithyroidal soft tissue or strap muscle invasion)"of the seventh edition was removed from the T stage and changed to the gross extrathyroidal extension invading only strap muscles, but there is still much controversy. It can be seen that different degrees of "extrathyroidal extension" have significant differences in the survival and prognosis of thyroid cancer. This article reviews the latest research progress of extrathyroidal extension, and discusses the significance and clinical research progress of it.

Entities:  

Keywords:  Extrathyroidal extension; Prognosis; Recurrence; Thyroid neoplasms

Mesh:

Year:  2019        PMID: 31550771     DOI: 10.3760/cma.j.issn.1673-0860.2019.09.018

Source DB:  PubMed          Journal:  Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi        ISSN: 1673-0860


  3 in total

1.  Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer.

Authors:  Yan Zhang; Xia Zhang; Jie Li; Qian Cai; Zhi Qiao; Yu Kun Luo
Journal:  Eur Radiol       Date:  2021-01-07       Impact factor: 5.315

2.  Prognostic factors in patients with persistent/recurrent differentiated thyroid carcinoma after comprehensive treatment

Authors:  Jianxing Wang; Yao Yao; Yichun Qian; Weiping Yao; Shuai Cheng; Xinyue Yuan; Yuan Zhang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-25

3.  Development of a Risk Predictive Model for Evaluating Immune Infiltration Status in Invasive Thyroid Carcinoma.

Authors:  Runming Pang; Chunxin Qin
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-03       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.